Effect of Betadine Vaginal Cleansing Before Cesarean Section to Reduce Postoperative Infectious Morbidity
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Povidone-iodine 5% solution.
- Who it may be relevant to
- Registry conditions: Cesarean Section, Surgical Site Infection, Endometritis. Basic parameters: No limits · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
This randomized controlled trial aims to evaluate the efficacy of preoperative vaginal cleansing with 5% povidone-iodine in reducing postoperative infectious morbidity among women undergoing cesarean section. The primary outcomes include wound-related complications, while secondary outcomes include postoperative fever, endometritis, wound infection, and white blood cell count.
Interventions
- Drug Povidone-iodine 5% solution
Vaginal cleansing with 5% povidone-iodine for 30 seconds before cesarean section.
Primary outcome measures
- Incidence of postoperative wound-related complications Time Frame: Within 8 weeks after cesarean section [Time frame: 8 weeks]
- Incidence of postoperative wound-related complications [Time frame: Within 8 weeks after cesarean section]
Secondary outcome measures (1)
- Postoperative fever (within 8 weeks) Postoperative WBC count (24 hours) Endometritis (within 8 weeks) Combined wound complications and endometritis [Time frame: 8 weeks]
Eligibility criteria
Inclusion criteria
\- Women undergoing elective or emergency cesarean section. Received prophylactic antibiotics before surgery
Exclusion criteria
- Active infection No prophylactic antibiotics Chorioamnionitis Placenta previa with antepartum hemorrhage
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Prevention
Study locations
Egypt · 1 center
- Al-Azhar University Hospital, Damietta — Damietta
Identifiers
NCT: NCT07715409 · DFM-IRB 00012367-26-03-017